πŸ‡ΊπŸ‡Έ FDA
Patent

US 10238646

Methods for treating pruritus

granted A61KA61K31/485A61K45/06

Quick answer

US patent 10238646 (Methods for treating pruritus) held by Trevi Therapeutics, Inc. expires Mon Mar 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Trevi Therapeutics, Inc.
Grant date
Tue Mar 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K31/485, A61K45/06, A61K9/0053, A61K9/2009